Antibiotic resistance

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 2, 1998, Pages 125-128

  Finch, R G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; EDITORIAL;

EID: 0031849267     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.2.125     Document Type: Editorial

References (21)

1. World Health Organization. (1997). Antimicrobial Resistance Monitoring Programme. WHO Drug Information 11, 248-9.
2. Lennox, A., Phillips, L., Monnet, D., McGowan, J. E., Tenover, F. & Gaynes, R. (1997). Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clinical Infectious Diseases 24, 211-5.
3. House of Lords Select Committee on Science and Technology. (1998). Resistance to antibiotics and other antimicrobial agents. Stationery Office, London.
4. Wiedemann, B. (1996). Epidemiology, control and treatment of multiresistant Gram-negative rods. Drugs 52, Suppl. 2, 95-100.
5. Laurichesse, H., Grimaud, O., Waight, P., Johnson, A. P., George, R. C. & Miller, E. (1998). Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995. Communicable Disease and Public Health 1, 22-7.
6. Caputo, G. M., Appelbaum, P. C. & Liu, H. H. (1993). Infections due to penicillin-resistant pneumococci. Clinical, epidemiologic, and microbiologic features. Archives of Internal Medicine 153, 1301-10.
7. Pallares, R., Linares, J., Vadillo, M., Cabellos, C., Manresa, F., Viladrich, P. F. et al. (1995). Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. New England Journal of Medicine 333, 474-80.
8. Jacobs, R. F., Kaplan, S. L., Schutze, G. E., Dajani, A. S., Leggiadro, R. J., Rim, C. S. et al. (1996). Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections. Antimicrobial Agents and Chemotherapy 40, 895-8.
9. Finch, R. G. (1997). In-vitro antimicrobial susceptibility testing: does it really matter? Journal of Chemotherapy 9, Suppl. 1, 3-6.
10. Voss, A. (1996). Staphylococcus aureus. Pan-European antibiotic resistance and infection control. Chemotherapie Journal 5, 5-6.
11. Ayliffe, G. A. J. (1997). The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases 24, Suppl. 1, S74-9.
12. Baquero, F. and the Task Force of the General Direction for Primary Health Planning of the Spanish Ministry of Health. (1996). Antibiotic resistance in Spain: what can be done? Clinical Infectious Diseases 23, 819-26.
13. Hastings, A., French, D. & McKinley, R. (1996). The development of a general practice formulary of drugs for out-of-hours care. Pharmaceutical Journal 256, 900-2.
14. Baquero, F. (1995). Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview. Microbial Drug Resistance 1, 115-20.
15. Chow, A. W., Hall, C. B., Klein, J. O., Kammer, R. B., Meyer, R. D. & Remington, J. S. (1992). Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration. Clinical Infectious Diseases 15, Suppl. 1, S62-88.
16. Froom, J., Culpepper, L., Jacobs, M., DeMelker, R. A., Green, L. A., van Buchem, L. et al. (1997). Antimicrobials for acute otitis media? A review from the International Primary Care Network. British Medical Journal 315, 98-102.
17. Schappert, S. M. (1992) Office visits for otitis media: United States, 1975-90. Vital and Health Statistics of the Centers for Disease Control/National Centers for Health Statistics 214, 3-18.
18. Leibovici, L. & Wysenbeek, A. J. (1991). Single-dose antibiotic treatment for symptomatic urinary tract infections in women: a meta-analysis of randomized trials. Quarterly Journal of Medicine 78, 43-57.
19. Norrby, S. R. (1990). Short-term treatment of uncomplicated lower urinary tract infections in women. Reviews of Infectious Diseases 12, 458-67.
20. Gris, P. (1996). Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study. Journal of Antimicrobial Chemotherapy 37, Suppl. C, 93-101.
21. Zachariah, J. (1996). A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections. Journal of Antimicrobial Chemotherapy 37, Suppl. C, 103-13.